Neurology

High Rate of Waning Botox Efficacy in Dystonia, Spasticity




A ‘surprisingly high’ number of patients with dystonia or spasticity who receive botulinum neurotoxin type A develop neutralizing antibodies to the toxin over time, new research shows.
Medscape Medical News

Source link






Related posts

The most useful investigative tools of neurology

Newsemia

Doubts about TMEM230 as a gene for parkinsonism

Newsemia

Friendship Bench—A Model for Accessible Mental Health Care

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy